Fendrick discusses impact of Value-Based Insurance Design on oncology drugs

IHPI member Mark Fendrick recently did an interview with the peer-reviewed journal Clinical Advances in Hematology & Oncology about the impact of Value-Based Insurance Design on oncology drugs. 

Read the PDF transcript HERE.